supplementary figure 3 - bmj
TRANSCRIPT
![Page 1: Supplementary Figure 3 - BMJ](https://reader030.vdocuments.us/reader030/viewer/2022012704/61a66a8c867a1b2a01325905/html5/thumbnails/1.jpg)
B
KRT7
APOC1
MSLNCLDN4
UBE2C
UBD
GDF15
MISPMMP7
EPCAM
REG4
KRT17KRT18
MMP11
MUC13
MYBL2
LGALS4
ETV4
COL1A1
MUC3A
CTHRC1HOXA10
HOXC10CLDN1
CXCL1
TOP2ATPX2
SOX9
AGR2
EPHB2
CDKN2A
PPP1R1BCLDN7
GRIN2D
APOE
BGN
MKI67MARCKSL1
SPP1
PKMYT1
FOXM1
CDC20
VIL1
HNF4AGPRC5ACLDN2
MMP1
CHI3L1
CRYABANGPTL1
PSD
RBPMS2
SOSTDC1
C16orf89
TCEAL2
PRIMA1
MAMDC2
PLIN4
FXYD1
HBA2
CFD
HBA1
PLNSST
PI16
LMOD1
SFRP1
PGM5−AS1
HSPB8 PNCKSYNPO2
ADH1B
PPP1R1APGM5FHL1
ATP4A
CKBCCL14
SYNMGIFHSPB6
HBB
CNN1
MYOC
ATP4B
DPT
ACTG2MYH11
GKN2
C2orf40
MAL
PGA5
GKN1PGA4
PGA3
0
3
6
9
12
−4 −2 0 2 4log2(Fold Change)
−log10(p
−valu
e)
DEGs of tumor versus paired normal samples in TCGA datasetA
NormalTumor
−2
−1
0
1
2
3
D Surgical resected samples
Targeted biopsies samples under magnifying endoscopy
p = 3.1e-06 p = 0.001
0
5
10
Tumor Normal
REG4
0.0
2.5
5.0
7.5
10.0
Tumor Normal
CLDN7
p = 0.0045
0
5
10
15
Tumor Normal
PGA3
p = 0.0037
0
5
10
15
Tumor Normal
GKN1
Malignant epithelial cells Non-malignant epithelial cells
To
p 5
0 g
en
es in
tu
mo
rTo
p 5
0 g
en
es in
no
rma
l
Sca
led
exp CG(97%) DGC(2%) IGC1(67%)
IGC2(34%)
IGC3(50%)IGC4(1%)
IGC5(15%)
MGC1(83%)
MGC2(39%)
MGC3(33%)
NC1(98%)
NC2(99%)
C
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any relianceSupplemental material placed on this supplemental material which has been supplied by the author(s) Gut
doi: 10.1136/gutjnl-2019-320368–12.:1 70 2021;Gut, et al. Zhang M